Researchers at McMaster University have invented a stable, affordable way to store fragile vaccines for weeks at a time at temperatures up to 40C, opening the way for life-saving anti-viral vaccines to reach remote and impoverished regions of the world.
The influenza A virus continues to pose one of the most pressing threats to global public health due to its tendency to cause a pandemic.
Seven researchers from across the disciplines have earned Early Researcher Awards to advance their work – a collective investment of nearly $1 million from the Province of Ontario.